Approved medicines for paediatric solid tumours in Europe: Lessons from the life cycle of a paediatric investigation plan
Background: Despite the positive changes brought by the Paediatric Regulation in the European Union (EU) in 2007, drug development in children remains challenging. Methods: To better understand the issues encountered to reach an authorisation for paediatric patients, we reviewed the pathway of the 1...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-12-01
|
| シリーズ: | EJC Paediatric Oncology |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2772610X24000503 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|